SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 72 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $13,472,813 | +5.1% | 656,250 | +21.8% | 0.03% | +6.7% |
| Q1 2024 | $12,821,393 | +1282039.3% | 538,714 | +803950.7% | 0.03% | – |
| Q1 2020 | $1,000 | -66.7% | 67 | -82.4% | 0.00% | – |
| Q4 2019 | $3,000 | -40.0% | 380 | -39.5% | 0.00% | – |
| Q3 2019 | $5,000 | -16.7% | 628 | -10.0% | 0.00% | – |
| Q2 2019 | $6,000 | +100.0% | 698 | +21.8% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 573 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -25.0% | 573 | +22.4% | 0.00% | – |
| Q3 2018 | $4,000 | +100.0% | 468 | +106.2% | 0.00% | – |
| Q2 2018 | $2,000 | -71.4% | 227 | -53.2% | 0.00% | – |
| Q1 2018 | $7,000 | – | 485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $19,588,000 | 3.91% |
| Ghost Tree Capital, LLC | 575,000 | $10,988,000 | 3.21% |
| Avidity Partners Management LP | 4,823,400 | $92,175,000 | 2.04% |
| BVF INC/IL | 2,486,429 | $47,516,000 | 1.85% |
| FRAZIER MANAGEMENT LLC | 1,188,135 | $22,705,000 | 1.82% |
| Nantahala Capital Management | 2,657,159 | $50,778,000 | 1.60% |
| Boxer Capital, LLC | 2,287,782 | $43,720,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,939,000 | 1.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,603 | $14,344,000 | 1.20% |
| PFM Health Sciences, LP | 1,856,738 | $35,482,000 | 1.04% |